JPX · 2689.T
OLBA HEALTHCARE HOLDINGS, Inc.
¥1,920+¥9 (+0.47%)
OLBA HEALTHCARE HOLDINGS, Inc.’s quoted price sits in the lower half of its reported 52-week range, 14.21% below the high.
Loading market information…
JPX · 6678.T · JPY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 06:30 AM UTC. Cached market data; not a live quote.
One-year closing-price history · JPY. Historical prices are not a forecast.
Techno Medica Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 22.46% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Techno Medica Co., Ltd.’s forward annual dividend is ¥129 per share, paid annual. The forward yield is 5.97% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Techno Medica Co., Ltd.’s next earnings report is currently expected on Nov 6, 2026. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Techno Medica Co., Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Techno Medica Co., Ltd. is a Japanese company that specializes in the entire lifecycle of in-vitro diagnostic analyzers, covering their research, development, manufacturing, distribution, and international trade. Their product portfolio includes automated systems for test tube preparation, urine aliquot, and RFID-based management solutions for both biological specimens and blood transfusions. The company also supplies a diverse range of analytical instruments for measuring blood gases, electrolytes, erythrocyte sedimentation rates, nutrient levels, sugar and acid content, and for performing urine chemistry tests. Furthermore, Techno Medica provides electronic medical charting systems, various pre-analytical devices, essential consumables, and comprehensive after-sales support. Established in 1987, the company's main office is located in Yokohama, Japan.
Latest available per-share figures in JPY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:02 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
¥1,920+¥9 (+0.47%)
OLBA HEALTHCARE HOLDINGS, Inc.’s quoted price sits in the lower half of its reported 52-week range, 14.21% below the high.
¥1,246-¥1 (-0.08%)
Satudora Holdings Co.,Ltd.’s quoted price sits in the upper half of its reported 52-week range, 6.17% below the high.
¥559+¥29 (+5.47%)
Medical System Network Co., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 2.1% below the high.
¥4,975-¥10 (-0.2%)
Hoshi Iryo-Sanki Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 17.08% below the high.
¥578-¥9 (-1.53%)
Japan Medical Dynamic Marketing, Inc.’s quoted price sits in the lower half of its reported 52-week range, 42.49% below the high.
¥1,438-¥8 (-0.55%)
Colan Totte.Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 9.9% below the high.
¥418+¥2 (+0.48%)
Daiken Medical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 14.52% below the high.
¥930¥0 (0.0%)
DVx Inc.’s quoted price sits in the lower half of its reported 52-week range, 36.21% below the high.
